Francisco Rodrı́guez-Esparragón

Author

Hospital Universitario de Gran Canaria Doctor Negrín ORCID

Also Known As

F Rodriguez-Esparragon, F Rodríguez Esparragón, F. Rodriguez-Esparragon, F. Rodríguez-Esparragón, FJ Rodríguez-Esparragón, Fancisco Rodriguez-Esparragon, Francisco J. Rodríguez-Esparragón, Francisco Javier Rodríguez Esparragón, Francisco Rodriguez-Esparragon, Francisco Rodriguez‐Esparragon

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario de Gran Canaria Doctor Negrín Universidad de Las Palmas de Gran Canaria Hospital Universitario Insular de Gran Canaria Universidad de La Laguna Instituto de Salud Carlos III

About

Francisco Rodrı́guez-Esparragón is an author at Hospital Universitario de Gran Canaria Doctor Negrín specializing in medicine, cardiovascular disease, and cardiovascular genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	139
2	Public Health	2	2	103
3	Engineering	1	1	19
4	Health Sciences	1	1	17
5	Biomedical Engineering	1	1	19

Francisco Rodrı́guez-Esparragón

Publications

408

Citations

H-Index

Page 1

	Year	Citations
Association of angiotensinogen m235t and a(-6)g gene polymorphisms with coronary heart disease with independence of essential hypertension: the procagene study José Rodríguez-Pérez, Francisco Rodrı́guez-Esparragón, Octavio Hernández‐Perera, Journal of the American College of Cardiology Genome-wide Association StudyHypertensionEpidemiologyGenetic DeterminantCardiovascular Epidemiology	2001	92
Allelic Variants of the Human Scavenger Receptor Class B Type 1 and Paraoxonase 1 on Coronary Heart Disease Francisco Rodrı́guez-Esparragón, José Rodríguez-Pérez, Yaridé Hernández-Trujillo, Arteriosclerosis Thrombosis and Vascular Biology	2005	61
Effects of Ozone Treatment on Personal Protective Equipment Contaminated with SARS-CoV-2 Bernardino Clavo, Elizabeth Córdoba-Lanús, Francisco Rodrı́guez-Esparragón, Antioxidants	2020	39
Insight into the role of CYBA A640G and C242T gene variants and coronary heart disease risk. A case-control study Antonio Macías-Reyes, Francisco Rodrı́guez-Esparragón, Araceli Caballero-Hidalgo, Free Radical Research	2008	35
The Effect of Methylenetetrahydrofolate Reductase C677T Common Variant on Hypertensive Risk Is Not Solely Explained by Increased Plasma Homocysteine Values Francisco Rodrı́guez-Esparragón, Octavio Hernández‐Perera, José Rodríguez-Pérez, Clinical and Experimental Hypertension	2003	33
Evaluation of Aloe Vera Coated Polylactic Acid Scaffolds for Bone Tissue Engineering Ricardo Donate, Maria Elena Alemán‐Domínguez, Mario Monzón, Applied Sciences Tissue EngineeringEngineeringBone Tissue EngineeringBiomaterials DesignBone Repair	2020	19
Long-Term Results with Adjuvant Ozone Therapy in the Management of Chronic Pelvic Pain Secondary to Cancer Treatment Bernardino Clavo, Minerva Navarro, Mario Federico, Pain Medicine Pain TherapySurgical OncologySpain EmailPain MedicineCancer Management	2020	17
Effects of Ozone Treatment on Health-Related Quality of Life and Toxicity Induced by Radiotherapy and Chemotherapy in Symptomatic Cancer Survivors Bernardino Clavo, Ángeles Cánovas-Molina, Yolanda Ramallo‐Fariña, International Journal of Environmental Research and Public Health	2023	17
Persistence of SARS-CoV-2 infection on personal protective equipment (PPE) Elizabeth Córdoba-Lanús, Omar García-Pérez, Sara Cazorla-Rivero, BMC Infectious Diseases	2021	15
Effects of ceramic additives and bioactive coatings on the degradation of polylactic acid‐based bone scaffolds under hydrolytic conditions Ricardo Donate, Mario Monzón, Maria Elena Alemán‐Domínguez, Journal of Biomedical Materials Research Part B Applied Biomaterials	2022	15

Page 1